Platform
Features
Pricing
0 followers
Follow
Tough on #Cancer not on Patients. Initiating Phase II trials on the Indenoisoquinolines, a new class of non-Camptothecins a novel anti-cancer fighting drug.
Industries
Headquarters
Employees
Links
Randall B Riggs
6 members
5 members
HQ
0 people
Merck
244 followers
Revvity
8 followers
Gilead Sciences
141 followers
Regeneron
109 followers
AtriCure
4 followers
Illumina
76 followers
Agilent Technologies
Apollo Global Management
41 followers
Verily Life Sciences
40 followers
Alexion Pharmaceuticals
38 followers
GRAIL
27 followers
Explore companies